NEW YORK, Jan. 27, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of XBiotech Inc. (“XBiotech”) (Nasdaq:XBIT) between April 15, 2015 and November 23, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Western District of Texas. If you purchased or otherwise acquired XBiotech securities between April 15, 2015 and November 23, 2015, your rights may be affected by this action. To get more information go to:
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
According to the complaint, the Company made materially false and misleading statements to investors and/or failed to disclose that: (1) a fewer number of per protocol patients were available for primary endpoint evaluation in the Phase III Study; (2) the data from 72 patients of the Phase III Study was compromised; (3) XBiotech did not adequately sample patients to accommodate data loss; and (4) as a result of not properly sampling patients, the Phase III Study would have reduced statistical power to demonstrate the proposed outcome.
If you suffered a loss in XBiotech you have until February 1, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge
US Raises Concerns Over Possible ASML EUV Machine Transfer to China
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates
Ukrainian Drone Makers Target Japan and Asia Defense Market
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation
BHP Shares Fall as Jansen Potash Project Costs Surge
NHTSA Investigates Fatal Tesla Model 3 Crash in Texas Amid Ongoing Autopilot and FSD Safety Scrutiny
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 



